The costs of crime during and after publicly-funded treatment for opioid use disorders: a population-level study for the state of California.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27981691)

Published in Addiction on December 15, 2016

Authors

Emanuel Krebs1, Darren Urada2, Elizabeth Evans2, David Huang2, Yih-Ing Hser2, Bohdan Nosyk1,2,3

Author Affiliations

1: British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.
2: UCLA Integrated Substance Abuse Program, Los Angeles, CA, USA.
3: Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.

Articles citing this

Estimating State Transitions for Opioid Use Disorders. Med Decis Making (2016) 0.76

Articles cited by this

Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA (2000) 14.17

Economic costs of diabetes in the U.S. in 2012. Diabetes Care (2013) 11.74

Estimating log models: to transform or not to transform? J Health Econ (2001) 11.10

CDC grand rounds: prescription drug overdoses - a U.S. epidemic. MMWR Morb Mortal Wkly Rep (2012) 5.77

A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry (2001) 5.26

Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ (2005) 4.52

An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J Subst Abuse Treat (2005) 3.46

The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction (1998) 3.41

Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction (2010) 3.41

Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend (2009) 2.26

The economic impact of obesity in the United States. Diabetes Metab Syndr Obes (2010) 2.22

Social costs of untreated opioid dependence. J Urban Health (2000) 2.18

The life course perspective on drug use: a conceptual framework for understanding drug use trajectories. Eval Rev (2007) 2.18

The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results. Addiction (2003) 2.14

Nonmedical Prescription Opioid Use and Use Disorders Among Adults Aged 18 Through 64 Years in the United States, 2003-2013. JAMA (2015) 2.14

"Every 'never' I ever said came true": transitions from opioid pills to heroin injecting. Int J Drug Policy (2013) 2.12

A call for evidence-based medical treatment of opioid dependence in the United States and Canada. Health Aff (Millwood) (2013) 2.09

The effectiveness of drug abuse treatment: a meta-analysis of comparison group studies. Drug Alcohol Depend (2002) 1.99

Income generating activities of people who inject drugs. Drug Alcohol Depend (2007) 1.95

Intertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993-2009. PLoS One (2013) 1.94

The cost of crime to society: new crime-specific estimates for policy and program evaluation. Drug Alcohol Depend (2010) 1.75

The Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality Among HIV-Positive People Who Inject Drugs. Clin Infect Dis (2015) 1.58

A long-term program of research on drug use and crime. Subst Use Misuse (1998) 1.55

Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006-10. Addiction (2015) 1.55

Polydrug use and implications for longitudinal research: ten-year trajectories for heroin, cocaine, and methamphetamine users. Drug Alcohol Depend (2008) 1.43

Good research practices for measuring drug costs in cost-effectiveness analyses: a societal perspective: the ISPOR Drug Cost Task Force report--Part II. Value Health (2009) 1.43

National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment. Am J Public Health (2015) 1.39

Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment. CMAJ (2012) 1.37

Cycling in and out of treatment; participation in methadone treatment in NSW, 1990-2002. Drug Alcohol Depend (2005) 1.32

Predicting long-term stable recovery from heroin addiction: findings from a 33-year follow-up study. J Addict Dis (2007) 1.29

The urgency of providing comprehensive and integrated treatment for substance abusers with HIV. Health Aff (Millwood) (2011) 1.29

Cross-system data linkage for treatment outcome evaluation: lessons learned from the California Treatment Outcome Project. Eval Program Plann (2008) 1.27

Proportional hazards frailty models for recurrent methadone maintenance treatment. Am J Epidemiol (2009) 1.26

Heroin addicts and methadone treatment in Albuquerque: a 22-year follow-up. Drug Alcohol Depend (1995) 1.25

Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials. BMJ (2005) 1.23

Reduction in crime by drug users on a methadone maintenance therapy programme in New Zealand. N Z Med J (2004) 1.22

Changes in Substance Abuse Treatment Use Among Individuals With Opioid Use Disorders in the United States, 2004-2013. JAMA (2015) 1.16

Characterizing durations of heroin abstinence in the California Civil Addict Program: results from a 33-year observational cohort study. Am J Epidemiol (2013) 1.05

Prescription opioid abuse: a literature review of the clinical and economic burden in the United States. Popul Health Manag (2014) 0.99

Drug use and crime: a historical review of research conducted by the UCLA Drug Abuse Research Center. Subst Use Misuse (1998) 0.98

Observed transition from opioid analgesic deaths toward heroin. Drug Alcohol Depend (2014) 0.98

Differences in onset and abuse/dependence episodes between prescription opioids and heroin: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Subst Abuse Rehabil (2011) 0.98

Adoption of evidence-based clinical innovations: the case of buprenorphine use by opioid treatment programs. Med Care Res Rev (2013) 0.97

Effect of methadone treatment on incarceration rates among injection drug users. Eur Addict Res (2008) 0.94

Criminal justice itreatment admissions for methamphetamine use in California: a focus on Proposition 36. J Psychoactive Drugs (2007) 0.89

Offender diversion into substance use disorder treatment: the economic impact of California's proposition 36. Am J Public Health (2013) 0.87

Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in publicly-funded facilities in California, USA: 1991-2012. Drug Alcohol Depend (2014) 0.85

Economic evaluation of interventions to treat opiate dependence : a review of the evidence. Pharmacoeconomics (2008) 0.85

Opioid substitution therapy-time to replace the term. Lancet (2015) 0.84

A day-by-day investigation of changes in criminal convictions before and after entering and leaving opioid maintenance treatment: a national cohort study. BMC Psychiatry (2013) 0.81

Criminal Activity or Treatable Health Condition? News Media Framing of Opioid Analgesic Abuse in the United States, 1998-2012. Psychiatr Serv (2015) 0.78

Lifetime history of heroin use is associated with greater drug severity among prescription opioid abusers. Addict Behav (2014) 0.78

Economic Evaluations of Opioid Use Disorder Interventions. Pharmacoeconomics (2016) 0.78

High-Cost Populations, The ACA, And More. Health Aff (Millwood) (2016) 0.76

Dynamics in the costs of criminality among opioid dependent individuals. Drug Alcohol Depend (2014) 0.76

Estimating State Transitions for Opioid Use Disorders. Med Decis Making (2016) 0.76